住友 誠

Medicine & Life Sciences

1. Adrenalectomy 11%
2. Androgen Receptors 12%
3. Androgens 19%
4. Apoptosis 12%
5. Bladder Diverticulum 9%
6. Bombesin 8%
7. cabazitaxel 14%
8. Carcinoma 9%
9. Castration 16%
10. Cystectomy 13%
11. Diverticulum 8%
12. Docetaxel 8%
13. Fatty Acid Synthases 8%
14. Gefitinib 11%
15. Groin 9%
16. Growth 14%
17. Kidney 15%
18. Kidney Neoplasms 23%
19. Lymphatic Vessels 7%
20. Molecular Targeted Therapy 8%
21. Multivariate Analysis 7%
22. Neoplasm Metastasis 23%
23. Neoplasms 32%
24. Nephrectomy 25%
25. Nephroureterectomy 14%
26. Neprilysin 41%
27. Neuropeptides 8%
28. Orchiectomy 9%
29. Prostate 18%
30. Prostate-Specific Antigen 21%
31. Prostatectomy 20%
32. Prostatic Neoplasms 81%
33. Prostatitis 11%
34. Protein Kinase C 8%
35. Recurrence 18%
36. Renal Cell Carcinoma 100%
37. Serum 8%
38. Survival 10%
39. Survivin 12%
40. Testis 8%
41. Therapeutics 14%
42. Tomography 8%
43. Topotecan 17%
44. Transurethral Resection of Prostate 9%
45. Ureter 11%
46. Urethral Stricture 8%
47. Urinary Bladder 13%
48. Urinary Bladder Neoplasms 17%
49. Urinary Catheters 8%
50. Vorinostat 13%